Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab

Willemsen, L.; Jol-van der Zijde, C.M.; Admiraal, R.; Putter, H.; Jansen-Hoogendijk, A.M.; Ostaijen-ten Dam, M.M.; ... ; Tol, M.J.D. van (2015)

Article / Letter to editor

• Antithymocyte globulin
• Alemtuzumab
• Hematopoietic stem cell transplantation
• Immune reconstitution
• Survival
• Children

• All authors: Willemsen, L.; Jol-van der Zijde, C.M.; Admiraal, R.; Putter, H.; Jansen-Hoogendijk, A.M.; Ostaijen-ten Dam, M.M.; Wijnen, J.T.; Kesteren, C. van; Waaijer, J.L.M.; Lankester, A.C.; Bredius, R.G.M.; Tol, M.J.D. van
• Date: 2015-03-31
• Journal: Biology of Blood and Marrow Transplantation
• Volume: 21
• Issue: 3
• Pages: 473 - 482
• DOI: doi:10.1016/j.bbmt.2014.11.674